These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Where the money is. Fitzgerald M Nat Biotechnol; 2006 Mar; 24(3):240-2. PubMed ID: 16525370 [No Abstract] [Full Text] [Related]
7. Korean biotechs seize opportunity to list on public markets. Louët S Nat Biotechnol; 2005 Oct; 23(10):1189-90. PubMed ID: 16211042 [No Abstract] [Full Text] [Related]
8. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related]
9. When your stock takes a nosedive. Jacobs T Nat Biotechnol; 2006 Feb; 24(2):144. PubMed ID: 16465152 [No Abstract] [Full Text] [Related]
10. 1Q13--Stocks reach all-time high. Yang W Nat Biotechnol; 2013 May; 31(5):378. PubMed ID: 23657383 [No Abstract] [Full Text] [Related]
11. Keeping it real with investors. Dipp M; Westphal C; Mirkin C; Baker J; Harper T; Harris C Nat Biotechnol; 2006 Feb; 24(2):133-5. PubMed ID: 16526102 [No Abstract] [Full Text] [Related]
18. Biotechs for pennies? Jacobs T Nat Biotechnol; 2004 Dec; 22(12):1509. PubMed ID: 15583652 [No Abstract] [Full Text] [Related]
19. Biotech IPOs--flop or pop? Jacobs T Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641 [No Abstract] [Full Text] [Related]
20. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related] [Next] [New Search]